Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $19.0B |
| FY2017, ended Dec 31, 2017 | $20.2B |
| FY2018, ended Dec 31, 2018 | $15.8B |
| FY2019, ended Dec 31, 2019 | $16.9B |
| FY2020, ended Dec 31, 2020 | $15.9B |
| FY2021, ended Dec 31, 2021 | $30.7B |
| FY2022, ended Dec 31, 2022 | $33.2B |
| FY2023, ended Dec 31, 2023 | $41.9B |
| FY2024, ended Dec 31, 2024 | $26.9B |
| FY2025, ended Dec 31, 2025 | $37.2B |
| Trailing 12 months to Jul 4, 2026 (through Q2 FY2026) | $50.1B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $16.2B |
| FY2017, ended Dec 31, 2017 | $20.3B |
| FY2018, ended Dec 31, 2018 | $25.1B |
| FY2019, ended Dec 31, 2019 | $22.6B |
| FY2020, ended Dec 31, 2020 | $20.1B |
| FY2021, ended Dec 31, 2021 | $36.5B |
| FY2022, ended Dec 31, 2022 | $41.5B |
| FY2023, ended Dec 31, 2023 | $34.7B |
| FY2024, ended Dec 31, 2024 | $30.7B |
| FY2025, ended Dec 31, 2025 | $32.5B |
| Trailing 12 months to Jul 4, 2026 (through Q2 FY2026) | $36.1B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $796M | $1.15B |
| FY2017, ended Dec 31, 2017 | $1.32B | $607M |
| FY2018, ended Dec 31, 2018 | $2.36B | $1.41B |
| FY2019, ended Dec 31, 2019 | $1.27B | $1.33B |
| FY2020, ended Dec 31, 2020 | $721M | $1.15B |
| FY2021, ended Dec 31, 2021 | $6.83B | $4.61B |
| FY2022, ended Dec 31, 2022 | $7.61B | $8.12B |
| FY2023, ended Dec 31, 2023 | $4.53B | $4.90B |
| FY2024, ended Dec 31, 2024 | $2.03B | $806M |
| FY2025, ended Dec 31, 2025 | $1.74B | −$188M |
| Trailing 12 months to Jul 4, 2026 (through Q2 FY2026) | $2.88B | $1.58B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.05B |
| FY2017, ended Dec 31, 2017 | $949M |
| FY2018, ended Dec 31, 2018 | $1.40B |
| FY2019, ended Dec 31, 2019 | $1.53B |
| FY2020, ended Dec 31, 2020 | $2.64B |
| FY2021, ended Dec 31, 2021 | $2.36B |
| FY2022, ended Dec 31, 2022 | $4.28B |
| FY2023, ended Dec 31, 2023 | $6.38B |
| FY2024, ended Dec 31, 2024 | $3.56B |
| FY2025, ended Dec 31, 2025 | $2.26B |
| Trailing 12 months to Jul 4, 2026 (through Q2 FY2026) | $2.48B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $4.38B |
| FY2017, ended Dec 31, 2017 | $3.80B |
| FY2018, ended Dec 31, 2018 | $4.29B |
| FY2019, ended Dec 31, 2019 | $4.37B |
| FY2020, ended Dec 31, 2020 | $5.34B |
| FY2021, ended Dec 31, 2021 | $5.67B |
| FY2022, ended Dec 31, 2022 | $6.67B |
| FY2023, ended Dec 31, 2023 | $6.83B |
| FY2024, ended Dec 31, 2024 | $6.93B |
| FY2025, ended Dec 31, 2025 | $7.10B |
| Trailing 12 months to Jul 4, 2026 (through Q2 FY2026) | $7.10B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 28.8% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 319M |
| FY2017, ended Dec 31, 2017 | 318M |
| FY2018, ended Dec 31, 2018 | 305M |
| FY2019, ended Dec 31, 2019 | 301M |
| FY2020, ended Dec 31, 2020 | 298M |
| FY2021, ended Dec 31, 2021 | 269M |
| FY2022, ended Dec 31, 2022 | 252M |
| FY2023, ended Dec 31, 2023 | 241M |
| FY2024, ended Dec 31, 2024 | 231M |
| FY2025, ended Dec 31, 2025 | 228M |
| Trailing 12 months to Jul 4, 2026 (through Q2 FY2026) | 227M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $5.17M | $56.5M | $15.7M |
| FY2017, ended Dec 31, 2017 | $90.3M | $64.2M | $7.07M |
| FY2018, ended Dec 31, 2018 | $854M | $73.4M | $24.1M |
| FY2019, ended Dec 31, 2019 | $299M | $90.4M | $16.1M |
| FY2020, ended Dec 31, 2020 | $39.5M | $73.9M | $11.8M |
| FY2021, ended Dec 31, 2021 | $3.28B | $136M | — |
| FY2022, ended Dec 31, 2022 | $2.76B | $137M | — |
| FY2023, ended Dec 31, 2023 | $1.55B | $130M | — |
| FY2024, ended Dec 31, 2024 | $2.22B | $132M | — |
| FY2025, ended Dec 31, 2025 | $700M | $133M | — |
| Trailing 12 months to Jul 4, 2026 (through Q2 FY2026) | $675M | $146M | — |
Valuation
At current price- Market Cap
- $61.4B
- P/E
- 21.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.7×
- Price / Book
- 2.8×
- EV / EBITDA
- 11.5×
Growth
Trailing 12 months- Revenue (TTM)
- $36.1B
- Revenue Growth YoY
- 17.2%
- Revenue CAGR 3Y
- −7.8%
- Revenue CAGR 5Y
- 10.0%
- EPS Growth YoY
- 125%
- Net Income Growth YoY
- 123%
Profitability
Trailing 12 months- Gross Margin
- 15.5%
- Operating Margin
- —
- Net Margin
- 8.0%
- FCF Margin
- 4.4%
- Return on Equity
- 13.6%
Earnings
Trailing 12 months- Net Income
- $2.88B
- EPS (diluted)
- $12.53
- EBITDA
- $5.76B
- Operating Income
- —
Balance Sheet
As of Jul 4, 2026- Cash and cash equivalents
- $2.48B
- Total Debt
- $7.10B
- Net Debt
- $4.62B
- Total Assets
- $37.0B
- Total Liabilities
- $13.7B
- Shareholders' Equity
- $22.1B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $4.42B
- Capital Expenditure
- $2.84B
- Free Cash Flow
- $1.58B
Dividends and risk
Last 12 months- Dividend Yield
- 0.8%
- Dividend / Share
- $2.24
- Beta (5Y)
- 1.84
Every ratio is calculated from the company’s reported figures.